An FDA denial, but not the last word on Merck combo lipid drug
March 06 2012
An experimental lipid-lowering combo drug developed by Merck hit a snag, but its real test is yet to come, says ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.